Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder

被引：0
作者：
H-L Cheng
H-S Liu
Y-J Lin
H H-W Chen
P-Y Hsu
T-Y Chang
C-L Ho
T-S Tzai
N-H Chow
机构：
[1] National Cheng Kung University,Department of Urology
[2] National Cheng Kung University,Departments of Microbiology and Immunology
[3] National Cheng Kung University,Department of Radiation Oncology
[4] Institute of Basic Medical Sciences,Department of Parasitology
[5] National Cheng Kung University,Department of Pathology
[6] National Cheng Kung University,undefined
[7] National Cheng Kung University,undefined
来源：
British Journal of Cancer | 2005年 / 92卷
关键词：
bladder cancer; protein tyrosine kinases; RON; MET; co-expression; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recepteur d'Origine Nantais (RON) is a distinct receptor tyrosine kinase in the c-met proto-oncogene family. We examined the mutational and expression patterns of RON in eight human uroepithelial cell lines. Biological effects of RON overexpression on cancer cells were investigated in vitro, and the prognostic significance of RON and/or c-met protein (MET) expression was analysed in a bladder cancer cohort (n=183). There was no evidence of mutation in the kinase domain of RON. Overexpression of RON using an inducible Tet-off system induced increased cell proliferation, motility, and antiapoptosis. Immunohistochemical analysis showed that RON was overexpressed in 60 cases (32.8%) of primary tumours, with 14 (23.3%) showing a high level of expression. Recepteur d'Origine Nantais expression was positively associated with histological grading, larger size, nonpapillary contour, and tumour stage (all P<0.01). In addition, MET was overexpressed in 82 cases (44.8%). Co-expressed RON and MET was significantly associated with decreased overall survival (P=0.005) or metastasis-free survival (P=0.01) in 35 cases (19.1%). Recepteur d'Origine Nantais-associated signalling may play an important role in the progression of human bladder cancer. Evaluation of RON and MET expression status may identify a subset of bladder-cancer patients who require more intensive treatment.
引用
收藏
页码：1906 / 1914
页数：8
相关论文
共 172 条
[1]  
Adam RM(2003)Signaling through PI3K/Akt mediates stretch and PDGF-BB-dependent DNA synthesis in bladder smooth muscle cells J Urol 169 2388-2393
[2]  
Roth JA(2000)Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples Genes Chromosomes Cancer 29 147-156
[3]  
Cheng HL(1997)Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines Hepatology 26 59-66
[4]  
Rice DC(2002)Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON Oncogene 21 6382-6386
[5]  
Khoury J(2002)Overexpression of J Clin Oncol 20 1544-1550
[6]  
Bauer SB(2001) as a prognostic indicator for transitional cell carcinoma of the urinary bladder. A comparison with p53 nuclear accumulation Clin Cancer Res 7 1957-1962
[7]  
Peters CA(2003)Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder Proc Am Assoc Cancer Res 44 397-5526
[8]  
Freeman MR(1996)The significance of macrophage stimulating protein (MSP)/RON signaling pathway in the progression of human bladder cancer Mol Cell Biol 16 5518-5285
[9]  
Angeloni D(1997)A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype Cancer Res 57 5281-2227
[10]  
Danilkovitch-Miagkova A(2000)Vascular endothelial growth factor is predictor of relapse and stage progression in superficial bladder cancer Mol Cell Biol 20 2218-3049
12345678910